182 results on '"Davis, Brian J."'
Search Results
2. ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy
3. Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis
4. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study
5. Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer
6. Supplementary Table 1 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
7. Supplementary Methods from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
8. Data from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
9. Supplementary Figure 1 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
10. Supplementary Figure Legends from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
11. Supplementary Figure 2 from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
12. SupplementaryFigure 1 from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
13. Supplementary Figure 3 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
14. SupplementaryFigure 1 from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
15. Supplementary Figure Legends from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
16. Supplementary Table 2 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
17. Supplementary Figure 2 from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
18. Data from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
19. Supplementary Methods from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
20. External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
21. Cost effectiveness of treatment strategies for high risk prostate cancer
22. A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient‐reported quality of life
23. The ABR 2021 Radiation Oncology Remote Examinations: Development, Administration, and Implications for the Future
24. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer
25. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
26. Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate Cancer
27. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement
28. Implications of medical board certification practices on family planning and professional trajectory for early career female radiation oncologists
29. Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy
30. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)
31. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer
32. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
33. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
34. A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients
35. Oligometastatic prostatic cancer recurrence: role of salvage lymph node dissection (sLND) and radiation therapy-stereotactic body radiation therapy (RT-SBRT)
36. Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer
37. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
38. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
39. Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience
40. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
41. Comparing bowel and urinary domains of patient‐reported quality of life at the end of and 3 months post radiotherapy between intensity‐modulated radiotherapy and proton beam therapy for clinically localized prostate cancer
42. Outcomes and Profiles of Older Patients Receiving Definitive Radiation Therapy for Muscle-Invasive Bladder Cancer at a Tertiary Medical Center
43. Evaluation of real-time guidewire navigation using virtual endoscopic 4D fluoroscopy
44. c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner
45. Brachytherapy Seed Localization from Fluoroscopic Images Using a Statistical Classifier
46. Trans-urethral Ultrasound: A New Tool for Diagnostic and Therapeutic Imaging in Prostate Cancer
47. Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group
48. 11C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities
49. Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence
50. The American Board of Radiology Initial Certification in Radiation Oncology: Moving Forward Through Collaboration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.